GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vita Life Sciences Ltd (ASX:VLS) » Definitions » Price-to-Owner-Earnings

Vita Life Sciences (ASX:VLS) Price-to-Owner-Earnings

: 13.71 (As of Today)
View and export this data going back to 2007. Start your Free Trial

As of today (2024-04-23), Vita Life Sciences's share price is A$2.33. Vita Life Sciences's Owner Earnings per Share (TTM) ended in Dec. 2023 was A$0.17. It's Price-to-Owner-Earnings for today is 13.71.


The historical rank and industry rank for Vita Life Sciences's Price-to-Owner-Earnings or its related term are showing as below:

ASX:VLS' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 7.55   Med: 17.86   Max: 61.88
Current: 13.82

During the past 13 years, the highest Price-to-Owner-Earnings of Vita Life Sciences was 61.88. The lowest was 7.55. And the median was 17.86.


ASX:VLS's Price-to-Owner-Earnings is ranked better than
77.49% of 422 companies
in the Drug Manufacturers industry
Industry Median: 27.38 vs ASX:VLS: 13.82

As of today (2024-04-23), Vita Life Sciences's share price is A$2.33. Vita Life Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.17. Therefore, Vita Life Sciences's PE Ratio for today is 14.04.

As of today (2024-04-23), Vita Life Sciences's share price is A$2.33. Vita Life Sciences's EPS without NRI for the trailing twelve months (TTM) ended in was A$0.17. Therefore, Vita Life Sciences's PE Ratio without NRI for today is 14.04.

During the past 13 years, Vita Life Sciences's highest PE Ratio without NRI was 38.10. The lowest was 6.25. And the median was 14.76.


Vita Life Sciences Price-to-Owner-Earnings Historical Data

The historical data trend for Vita Life Sciences's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vita Life Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.18 8.77 11.88 9.82 10.47

Vita Life Sciences Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.88 - 9.82 - 10.47

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vita Life Sciences's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vita Life Sciences Price-to-Owner-Earnings Distribution

For the Drug Manufacturers industry and Healthcare sector, Vita Life Sciences's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Vita Life Sciences's Price-to-Owner-Earnings falls into.



Vita Life Sciences Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Vita Life Sciences's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=2.33/0.17
=13.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vita Life Sciences  (ASX:VLS) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Vita Life Sciences Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Vita Life Sciences's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Vita Life Sciences (ASX:VLS) Business Description

Traded in Other Exchanges
N/A
Address
Bath Road Kirrawee, Unit 1/ 102, Sydney, NSW, AUS, 2232
Vita Life Sciences Ltd is an Australian based pharmaceutical and healthcare company involved in formulating, packaging, sales, and distribution of vitamins and supplements. The company produces a wide range of premium supplements, vitamins, minerals, herbs and superfoods catered to all age categories and health conditions. The company markets its products through pharmacies and health food stores under the VitaHealth, Herbs of Gold brands throughout Asia-Pacific region.

Vita Life Sciences (ASX:VLS) Headlines

No Headlines